![Researcher looking at a book](https://www.xenotech.com/wp-content/uploads/2020/02/resource-masthead2-909x1024.jpg)
The Basics of In Vitro Xenobiotic Metabolism and Drug-Drug Interaction Investigations: Applicability to All Xenobiotics
Since SOT’s 59th Annual Meeting and ToxExpo has been canceled due to COVID-19 concerns, we are bringing the tradeshow to you! SOT is hosting this course virtually on April 3rd from 12-3:30pm EDT. Our VP of Consulting, Dr. Brian Ogilvie, will be conducting the workshop alongside our founder, Andrew Parkinson, and an excellent list of presenters including:
- Introductory Remarks on Xenobiotic Metabolism and Course Overview – Andrew Parkinson, XPD Consulting
- The Basics of In Vitro CYP Inhibition Studies for Regulatory Submission and Risk Assessment – Brian Ogilvie, XenoTech
- The Basics of In Vitro CYP Induction Studies for Regulatory Submission – Diane Ramsden, Alnylam Pharmaceuticals
- In Vitro Reaction Phenotyping and the Toxicological Burden of Reactive Metabolites – Jed Lampe, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
- Xenobiotic Transporter Studies for Regulatory Submission – Caroline Lee, Arena Pharmaceuticals
- The Science of Drug Interactions Is Applicable to All Xenobiotics – Andrew Parkinson, XPD Consulting
If you cannot attend, a recording of the virtual course will become available to registrants on SOT’s website approximately 1 week after the event. The course number for the workshop is AM07.
Register through SOT to view webinar & Download slides